In ANI's New Day trial, patients were randomized to an induction phase to receive either a single Iluvien injection or a series of five monthly injections of aflibercept, followed by supplemental ...

ADF Group has secured a contract to supply steel structures for a new infrastructure project in the energy sector in the province of Quebec. The Quebec-based steel superstructures fabricator said ...

Fiserv targeted 2025 earnings in a range between $10.15 and $10.30 a share, boosting the lower end of its previous target by 5 cents a share. The company tightened its sales target, and now ...

Tesla expected its vehicle business to "return to growth" for 2025. Is that still in the cards? Cantor Fitzgerald analyst Andres Sheppard wrote recently that he thinks the company will lower its ...

General Dynamics recorded higher earnings and revenue in the second quarter on the back of strong ordering activity in its marine and aerospace divisions. The aerospace and defense company posted a ...

I am looking to retire at 62. I’m single with a 12-year-old daughter, splitting parenting time with my ex-wife. I pay $1,000 ...

Rogers Communications upgraded its service revenue growth as it integrates its recent acquisition of Maple Leafs Sports Entertainment after revenue rose in the second quarter. The Canadian telecom ...

Tesla's stock is down 18% so far this year, and some analysts wonder if the company will lower its full-year forecast when it ...

Tesla's second-quarter results are on the docket for Wednesday afternoon, and these are the big numbers Wall Street will be watching for. On adjusted earnings per share, analysts tracked by FactSet ...

Lennox International upgraded its expectations for the full year after posting growth in profit and revenue in the second quarter. The provider of climate control solutions on Wednesday said it ...

AT&T maintained its revenue growth outlook for the year but now expects mobility service revenue growth of 3% or better and consumer fiber broadband revenue growth in the mid-to-high teens. It ...

For the third quarter, the stent maker forecast earnings in a range between 44 cents and 46 cents a share on sales growth of about 17%-to-19%. On an adjusted basis, Boston Sci targeted earnings ...